Traws Pharma, Inc. (TRAW) stock
TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.23−0.03 (-10.27%)
Close on Nov 17, 2026Market cap $3.59MP/E –Yield –
Traws Pharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Traws Pharma's operating cash flow for the twelve months ending Jun 30, 2026 was -$16.85M. For fiscal 2025 it was -$18.19M. The highest annual figure on record is $1.63M in fiscal 2012.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$18.19M | – |
| FY2024 | Dec 31, 2024 | -$29.79M | – |
| FY2023 | Dec 31, 2023 | -$17.93M | – |
| FY2022 | Dec 31, 2022 | -$16.29M | – |
| FY2021 | Dec 31, 2021 | -$19.49M | – |
| FY2020 | Dec 31, 2020 | -$23.08M | – |
| FY2019 | Dec 31, 2019 | -$20.83M | – |
| FY2018 | Dec 31, 2018 | -$22.70M | – |
| FY2017 | Dec 31, 2017 | -$23.82M | – |
| FY2016 | Dec 31, 2016 | -$15.81M | – |
| FY2015 | Dec 31, 2015 | -$31.24M | – |
| FY2014 | Dec 31, 2014 | -$57.65M | – |
| FY2013 | Dec 31, 2013 | -$61.38M | -3859.0% |
| FY2012 | Dec 31, 2012 | $1.63M | – |
| FY2011 | Dec 31, 2011 | -$14.17M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.50M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.58M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.76M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.01M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.98M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.44M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.04M | – |
| Q3 FY2024 | Sep 30, 2024 | -$11.48M | – |
| Q2 FY2024 | Jun 30, 2024 | -$9.85M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.42M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.43M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.47M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.49M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.54M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.88M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.90M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.21M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.30M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.27M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.27M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.31M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.65M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.47M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.76M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.38M | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.46M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.36M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.96M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.91M | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.60M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.41M | – |
| Q3 FY2018 | Sep 30, 2018 | -$7.15M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.62M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.51M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.67M | – |
| Q3 FY2017 | Sep 30, 2017 | -$7.40M | – |
| Q2 FY2017 | Jun 30, 2017 | -$5.69M | – |
| Q1 FY2017 | Mar 31, 2017 | -$6.06M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.36M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.86M | – |
See a number that looks wrong?